Statins and running: new study to reveal hidden effects on endurance athletes
NCT ID NCT07401017
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study looks at how the cholesterol-lowering drug rosuvastatin affects fitness and muscle symptoms in people who run long distances at least three times a week. Researchers will compare runners taking rosuvastatin to those not taking it over three months, measuring changes in oxygen use and muscle discomfort. The goal is to understand if this statin interferes with endurance training or increases muscle problems.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DYSLIPIDEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Taipei medical university
Taipei, 116, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Hormone therapy may shield menopausal hearts and brains โ a trial puts it to the test
- Could vitamin d levels influence cholesterol in obese diabetes patients?
- Could a tropical oil and green exercise boost fat burning and calm your mind?
- Sugarcane supplement and exercise may team up to tame cholesterol
- Could a common cholesterol drug boost mood treatment?
- Could vinegar and fasting fix prediabetes cholesterol?